Share Price and Basic Stock Data
Last Updated: December 18, 2025, 3:12 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chennai Meenakshi Multispeciality Hospital Ltd operates in the healthcare sector, focusing on providing comprehensive medical services. The company reported sales of ₹38.19 Cr for the fiscal year ending March 2023, which marked an increase from ₹30.86 Cr in the previous year. This upward trajectory in revenue highlights a recovery from the pandemic’s impact, as the hospital continues to cater to a growing patient base. In the subsequent fiscal year, sales are projected to decline slightly to ₹37.38 Cr, indicating potential challenges in maintaining growth momentum. However, quarterly sales figures show some resilience, with the latest reported quarterly revenue at ₹10.07 Cr for December 2023, suggesting that demand remains relatively stable despite overall economic pressures.
Profitability and Efficiency Metrics
The profitability of Chennai Meenakshi Multispeciality Hospital appears to be under pressure, as evidenced by its net profit margin, which stood at -1.73% for the latest fiscal year. This is a stark contrast to the previous fiscal year, where the net profit margin had reached 3.11%. The operating profit margin (OPM) has also seen fluctuations, most recently recorded at 3.71%, down from 12.66% in the prior year. The declining margins raise concerns about the efficiency of operations and cost management, particularly as expenses surged to ₹35.48 Cr in FY 2024. Furthermore, the interest coverage ratio (ICR) at 0.71x indicates that the hospital is struggling to cover its interest obligations, which could become a significant risk if the trend continues.
Balance Sheet Strength and Financial Ratios
Chennai Meenakshi’s balance sheet reflects a challenging financial position, with total borrowings at ₹10.63 Cr and reserves declining to -₹10.04 Cr. The negative reserves suggest that the company has accumulated losses that exceed its equity, posing a risk to financial stability. The current ratio of 0.53 indicates liquidity issues, as the company has less than one rupee in current assets for every rupee in current liabilities. Additionally, the price-to-book value ratio stands at -12.21x, further illustrating the disconnect between market valuation and the company’s financial health. However, the asset turnover ratio of 1.54% suggests that the company is utilizing its assets effectively to generate revenue, which is a positive sign amidst the overall financial strain.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Chennai Meenakshi Multispeciality Hospital reveals a significant promoter holding of 57.10%, which may instill some confidence among investors regarding long-term commitment. However, foreign institutional investors (FIIs) have not shown interest, and domestic institutional investors (DIIs) hold a mere 0.14%. This lack of institutional backing could indicate limited confidence in the company’s future prospects. The total number of shareholders has gradually increased to 8,671, suggesting a growing interest from retail investors. Yet, the absence of dividends in recent years coupled with the negative earnings per share (EPS) of -1.84 for FY 2025 raises questions about the company’s ability to generate returns for shareholders in the near term.
Outlook, Risks, and Final Insight
Looking ahead, Chennai Meenakshi Multispeciality Hospital faces a mixed outlook. While the healthcare sector remains integral and demand for medical services is likely to persist, the company’s financial metrics raise concerns. The risk of sustained losses and negative profitability could deter potential investors, particularly if operational efficiencies are not improved. Additionally, the heavy reliance on promoter holding without significant institutional support could create volatility in stock performance. Investors should weigh the potential for recovery against these risks, considering that any turnaround strategy would require effective cost management and operational improvements. Overall, while the hospital has strengths in asset utilization, the financial challenges it faces could overshadow its growth potential in the near term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 41.6 Cr. | 124 | 194/120 | 8.48 | 117 | 2.82 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 22.2 Cr. | 21.2 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 8.55 Cr. | 8.27 | 20.8/8.13 | 95.0 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 112 Cr. | 59.9 | 98.7/55.2 | 24.8 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 19.4 Cr. | 3.59 | 7.29/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 25,659.71 Cr | 739.94 | 92.55 | 99.39 | 0.33% | 15.48% | 14.81% | 9.04 |
All Competitor Stocks of Chennai Meenakshi Multispeciality Hospital Ltd
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.93 | 6.37 | 7.10 | 7.63 | 9.88 | 9.07 | 9.51 | 10.07 | 9.55 | 8.75 | 8.07 | 8.83 | 9.17 |
| Expenses | 6.88 | 5.87 | 6.44 | 6.84 | 8.84 | 8.66 | 8.96 | 9.80 | 9.07 | 8.68 | 8.29 | 9.20 | 8.83 |
| Operating Profit | 0.05 | 0.50 | 0.66 | 0.79 | 1.04 | 0.41 | 0.55 | 0.27 | 0.48 | 0.07 | -0.22 | -0.37 | 0.34 |
| OPM % | 0.72% | 7.85% | 9.30% | 10.35% | 10.53% | 4.52% | 5.78% | 2.68% | 5.03% | 0.80% | -2.73% | -4.19% | 3.71% |
| Other Income | 0.06 | 0.06 | 0.08 | 0.10 | 0.11 | 0.10 | 0.04 | 0.15 | 0.18 | 0.08 | 0.08 | 0.26 | 0.42 |
| Interest | 0.23 | 0.22 | 0.22 | 0.22 | 0.22 | 0.23 | 0.23 | 0.23 | 0.24 | 0.24 | 0.23 | 0.23 | 0.22 |
| Depreciation | 0.31 | 0.31 | 0.29 | 0.29 | 0.29 | 0.27 | 0.30 | 0.30 | 0.29 | 0.31 | 0.31 | 0.31 | 0.23 |
| Profit before tax | -0.43 | 0.03 | 0.23 | 0.38 | 0.64 | 0.01 | 0.06 | -0.11 | 0.13 | -0.40 | -0.68 | -0.65 | 0.31 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 60.94% | 0.00% | 33.33% | -63.64% | 446.15% | -5.00% | -1.47% | -3.08% | 3.23% |
| Net Profit | -0.43 | 0.04 | 0.23 | 0.38 | 0.25 | 0.02 | 0.04 | -0.04 | -0.44 | -0.38 | -0.67 | -0.63 | 0.31 |
| EPS in Rs | -0.58 | 0.05 | 0.31 | 0.51 | 0.33 | 0.03 | 0.05 | -0.05 | -0.59 | -0.51 | -0.90 | -0.84 | 0.42 |
Last Updated: July 16, 2025, 10:25 am
Below is a detailed analysis of the quarterly data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 9.17 Cr.. The value appears strong and on an upward trend. It has increased from 8.83 Cr. (Dec 2024) to 9.17 Cr., marking an increase of 0.34 Cr..
- For Expenses, as of Mar 2025, the value is 8.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.20 Cr. (Dec 2024) to 8.83 Cr., marking a decrease of 0.37 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.34 Cr.. The value appears strong and on an upward trend. It has increased from -0.37 Cr. (Dec 2024) to 0.34 Cr., marking an increase of 0.71 Cr..
- For OPM %, as of Mar 2025, the value is 3.71%. The value appears strong and on an upward trend. It has increased from -4.19% (Dec 2024) to 3.71%, marking an increase of 7.90%.
- For Other Income, as of Mar 2025, the value is 0.42 Cr.. The value appears strong and on an upward trend. It has increased from 0.26 Cr. (Dec 2024) to 0.42 Cr., marking an increase of 0.16 Cr..
- For Interest, as of Mar 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Dec 2024) to 0.22 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Mar 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Dec 2024) to 0.23 Cr., marking a decrease of 0.08 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -0.65 Cr. (Dec 2024) to 0.31 Cr., marking an increase of 0.96 Cr..
- For Tax %, as of Mar 2025, the value is 3.23%. The value appears to be increasing, which may not be favorable. It has increased from -3.08% (Dec 2024) to 3.23%, marking an increase of 6.31%.
- For Net Profit, as of Mar 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -0.63 Cr. (Dec 2024) to 0.31 Cr., marking an increase of 0.94 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.42. The value appears strong and on an upward trend. It has increased from -0.84 (Dec 2024) to 0.42, marking an increase of 1.26.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:58 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.59 | 18.71 | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 38.19 | 37.38 | 33.76 | 36.12 |
| Expenses | 15.21 | 16.57 | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 35.16 | 35.48 | 33.96 | 36.37 |
| Operating Profit | 2.38 | 2.14 | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 1.90 | -0.20 | -0.25 |
| OPM % | 13.53% | 11.44% | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 7.93% | 5.08% | -0.59% | -0.69% |
| Other Income | 0.30 | -0.54 | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.28 | 0.85 | 1.29 |
| Interest | 1.39 | 1.38 | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.92 | 0.91 | 0.90 |
| Depreciation | 0.81 | 1.19 | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 | 1.16 | 1.11 |
| Profit before tax | 0.48 | -0.97 | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.10 | -1.42 | -0.97 |
| Tax % | 8.33% | 0.00% | 0.00% | 0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | 530.00% | -3.52% | |
| Net Profit | 0.45 | -0.97 | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | -0.43 | -1.37 | -0.91 |
| EPS in Rs | 0.60 | -1.30 | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | -0.58 | -1.83 | -1.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -315.56% | 167.01% | -263.08% | 241.51% | -96.67% | 1000.00% | -327.27% | 418.40% | -77.64% | -148.31% | -218.60% |
| Change in YoY Net Profit Growth (%) | 0.00% | 482.57% | -430.09% | 504.59% | -338.18% | 1096.67% | -1327.27% | 745.67% | -496.04% | -70.68% | -70.29% |
Chennai Meenakshi Multispeciality Hospital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 26% |
| 3 Years: | 21% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:56 pm
Balance Sheet
Last Updated: December 4, 2025, 2:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Reserves | -11.97 | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.80 | -9.36 | -10.04 |
| Borrowings | 12.74 | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 11.42 | 10.63 | 10.63 |
| Other Liabilities | 10.98 | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.35 | 11.72 | 13.76 | 14.19 |
| Total Liabilities | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
| Fixed Assets | 15.11 | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 14.66 | 13.77 | 13.29 |
| CWIP | 0.47 | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.64 | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.16 | 8.15 | 8.73 | 8.96 |
| Total Assets | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
Below is a detailed analysis of the balance sheet data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.47 Cr..
- For Reserves, as of Sep 2025, the value is -10.04 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -9.36 Cr. (Mar 2025) to -10.04 Cr., marking a decline of 0.68 Cr..
- For Borrowings, as of Sep 2025, the value is 10.63 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 10.63 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.76 Cr. (Mar 2025) to 14.19 Cr., marking an increase of 0.43 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22.25 Cr.. The value appears to be improving (decreasing). It has decreased from 22.50 Cr. (Mar 2025) to 22.25 Cr., marking a decrease of 0.25 Cr..
- For Fixed Assets, as of Sep 2025, the value is 13.29 Cr.. The value appears to be declining and may need further review. It has decreased from 13.77 Cr. (Mar 2025) to 13.29 Cr., marking a decrease of 0.48 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 8.96 Cr.. The value appears strong and on an upward trend. It has increased from 8.73 Cr. (Mar 2025) to 8.96 Cr., marking an increase of 0.23 Cr..
- For Total Assets, as of Sep 2025, the value is 22.25 Cr.. The value appears to be declining and may need further review. It has decreased from 22.50 Cr. (Mar 2025) to 22.25 Cr., marking a decrease of 0.25 Cr..
However, the Borrowings (10.63 Cr.) are higher than the Reserves (-10.04 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.36 | -9.99 | -9.18 | -10.94 | -8.45 | -10.10 | -9.03 | -10.84 | -4.89 | -7.60 | -9.52 | -10.83 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11.83 | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 11.28 | 6.25 | 8.65 |
| Inventory Days | 36.25 | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 | 21.50 | 24.49 |
| Days Payable | 112.88 | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 88.74 | 51.61 | 89.40 |
| Cash Conversion Cycle | -64.80 | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -54.75 | -23.85 | -56.26 |
| Working Capital Days | -171.61 | -185.72 | -143.60 | -178.91 | -123.83 | -125.76 | -95.83 | -170.78 | -81.73 | -67.28 | -74.02 | -98.71 |
| ROCE % | 22.61% | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% | 11.08% | -5.14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Diluted EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Cash EPS (Rs.) | -0.28 | 0.97 | 2.77 | 6.89 | 0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Revenue From Operations / Share (Rs.) | 46.62 | 51.15 | 38.25 | 42.02 | 26.08 |
| PBDIT / Share (Rs.) | 0.86 | 2.92 | 4.49 | 8.21 | 1.55 |
| PBIT / Share (Rs.) | -0.68 | 1.37 | 2.91 | 6.64 | -0.14 |
| PBT / Share (Rs.) | -1.91 | 0.13 | 1.71 | 5.32 | -1.67 |
| Net Profit / Share (Rs.) | -1.84 | -0.57 | 1.19 | 5.32 | -1.67 |
| PBDIT Margin (%) | 1.86 | 5.70 | 11.73 | 19.54 | 5.93 |
| PBIT Margin (%) | -1.47 | 2.67 | 7.60 | 15.80 | -0.56 |
| PBT Margin (%) | -4.10 | 0.27 | 4.48 | 12.66 | -6.41 |
| Net Profit Margin (%) | -3.94 | -1.11 | 3.11 | 12.66 | -6.41 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 732.31 | -511.80 | 0.00 |
| Return on Capital Employeed (%) | -5.00 | 8.42 | 18.60 | 46.54 | -1.49 |
| Return On Assets (%) | -6.10 | -1.87 | 3.95 | 18.58 | -6.50 |
| Long Term Debt / Equity (X) | -5.63 | -33.52 | 87.39 | -13.68 | -2.41 |
| Total Debt / Equity (X) | -5.63 | -34.86 | 87.39 | -13.68 | -2.41 |
| Asset Turnover Ratio (%) | 1.54 | 1.69 | 1.30 | 1.55 | 1.01 |
| Current Ratio (X) | 0.53 | 0.64 | 0.76 | 0.65 | 0.50 |
| Quick Ratio (X) | 0.49 | 0.60 | 0.72 | 0.62 | 0.45 |
| Inventory Turnover Ratio (X) | 83.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.71 | 2.37 | 3.76 | 6.23 | 1.02 |
| Interest Coverage Ratio (Post Tax) (X) | -0.50 | 0.53 | 2.00 | 5.04 | -0.09 |
| Enterprise Value (Cr.) | 30.27 | 32.82 | 19.95 | 24.68 | 15.65 |
| EV / Net Operating Revenue (X) | 0.86 | 0.85 | 0.69 | 0.78 | 0.80 |
| EV / EBITDA (X) | 46.65 | 15.06 | 5.95 | 4.02 | 13.54 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| Price / BV (X) | -12.21 | -77.01 | 114.51 | -22.26 | -1.53 |
| Price / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| EarningsYield | -0.05 | -0.01 | 0.06 | 0.22 | -0.17 |
After reviewing the key financial ratios for Chennai Meenakshi Multispeciality Hospital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from 0.97 (Mar 24) to -0.28, marking a decrease of 1.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.62. It has decreased from 51.15 (Mar 24) to 46.62, marking a decrease of 4.53.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 2. It has decreased from 2.92 (Mar 24) to 0.86, marking a decrease of 2.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.37 (Mar 24) to -0.68, marking a decrease of 2.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.91. This value is below the healthy minimum of 0. It has decreased from 0.13 (Mar 24) to -1.91, marking a decrease of 2.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 2. It has decreased from -0.57 (Mar 24) to -1.84, marking a decrease of 1.27.
- For PBDIT Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 10. It has decreased from 5.70 (Mar 24) to 1.86, marking a decrease of 3.84.
- For PBIT Margin (%), as of Mar 25, the value is -1.47. This value is below the healthy minimum of 10. It has decreased from 2.67 (Mar 24) to -1.47, marking a decrease of 4.14.
- For PBT Margin (%), as of Mar 25, the value is -4.10. This value is below the healthy minimum of 10. It has decreased from 0.27 (Mar 24) to -4.10, marking a decrease of 4.37.
- For Net Profit Margin (%), as of Mar 25, the value is -3.94. This value is below the healthy minimum of 5. It has decreased from -1.11 (Mar 24) to -3.94, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.00. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to -5.00, marking a decrease of 13.42.
- For Return On Assets (%), as of Mar 25, the value is -6.10. This value is below the healthy minimum of 5. It has decreased from -1.87 (Mar 24) to -6.10, marking a decrease of 4.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -5.63. This value is below the healthy minimum of 0.2. It has increased from -33.52 (Mar 24) to -5.63, marking an increase of 27.89.
- For Total Debt / Equity (X), as of Mar 25, the value is -5.63. This value is within the healthy range. It has increased from -34.86 (Mar 24) to -5.63, marking an increase of 29.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has decreased from 1.69 (Mar 24) to 1.54, marking a decrease of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1.5. It has decreased from 0.64 (Mar 24) to 0.53, marking a decrease of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.49, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 83.36. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 83.36, marking an increase of 83.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 3. It has decreased from 2.37 (Mar 24) to 0.71, marking a decrease of 1.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 3. It has decreased from 0.53 (Mar 24) to -0.50, marking a decrease of 1.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 30.27. It has decreased from 32.82 (Mar 24) to 30.27, marking a decrease of 2.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.85 (Mar 24) to 0.86, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 46.65. This value exceeds the healthy maximum of 15. It has increased from 15.06 (Mar 24) to 46.65, marking an increase of 31.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For Price / BV (X), as of Mar 25, the value is -12.21. This value is below the healthy minimum of 1. It has increased from -77.01 (Mar 24) to -12.21, marking an increase of 64.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.05, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chennai Meenakshi Multispeciality Hospital Ltd:
- Net Profit Margin: -3.94%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.49
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 92.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -5.63
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.94%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | New No.70, Old No.149, Chennai (Madras) Tamil Nadu 600004 | cmmhospitals@gmail.com http://www.cmmh.in |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. R Gomathi | Managing Director |
| Mrs. Jayanthi Radhakrishnan | Managing Director |
| Mr. Edward M Prabhakar | Non Executive Director |
| Mr. Akash Prabhakar | Non Executive Director |
| Mr. K Meyyanathan | Independent Director |
| Mr. N Rajkumar | Independent Director |
| Ms. Shama Dhilip | Ind. Non-Executive Director |
| Mr. K M Mohandass | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Chennai Meenakshi Multispeciality Hospital Ltd?
Chennai Meenakshi Multispeciality Hospital Ltd's intrinsic value (as of 18 December 2025) is 6.32 which is 87.31% lower the current market price of 49.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 37.2 Cr. market cap, FY2025-2026 high/low of 57.5/28.3, reserves of ₹-10.04 Cr, and liabilities of 22.25 Cr.
What is the Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd?
The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd is 37.2 Cr..
What is the current Stock Price of Chennai Meenakshi Multispeciality Hospital Ltd as on 18 December 2025?
The current stock price of Chennai Meenakshi Multispeciality Hospital Ltd as on 18 December 2025 is 49.8.
What is the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks is 57.5/28.3.
What is the Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd?
The Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd is .
What is the Book Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Book Value of Chennai Meenakshi Multispeciality Hospital Ltd is 3.44.
What is the Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd?
The Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd is 0.00 %.
What is the ROCE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROCE of Chennai Meenakshi Multispeciality Hospital Ltd is 5.14 %.
What is the ROE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROE of Chennai Meenakshi Multispeciality Hospital Ltd is %.
What is the Face Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Face Value of Chennai Meenakshi Multispeciality Hospital Ltd is 10.0.